disappoint guidanc margin expans keep us construct
morn baxter report result expect report basi
low end rang oper basi issu soft guidanc
report revenu vs street adjust ep vs street
caus share sell main reason revenu soft lower
outlook medic deliveri nutrit miss street
respect posit side margin came better expect gm
op margin core piec thesi believ stori
continu addit manag reiter motiv along
healthi share repurchas see larg share appreci strategi overal
believ set bit riskier result solid reiter
ow rate
result report sale miss street estim
oper growth ex us cyclo acquisit currenc
guidanc gross margin bp street op
margin beat adjust cash ep beat street
soft guidanc report basi compani brought full year sale
guidanc previous expect constant
currenc basi growth oper basi also trim
respect op margin expans guidanc came
expans y/i previous come gross
margin bottom line rais full year ep guidanc low end
rang previous mostli due lower tax rate drive
beat guidanc call report revenu growth
cc oper basi adjust ep came
well street report revenu growth adjust ep
point call main headwind quarter revenu
perspect medic deliveri clinic nutrit segment miss
street respect total busi fail
ramp back pre-hurrican suppli level impact shift custom
demand destock distributor term guidanc expect
reset year manag close vest commentari
understand risk stori said
compani reiter commit long-rang plan analyst day
call compound-annual-growth-rate compound-annual-growth-rate thu busi
irrespect deal acceler go forward continu
price pressur gener competit deal execut
intra-day price
ebitda
assum net debt s/o
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
lastli compani reiter commit capit deploy especi size
one strongest balanc sheet med tech given manag
previou track record integr asset could highli increment acceler
corpor growth rate provid accret bottom line
stock stock nearli print disappoint
result below-street guidanc agre quarter disappoint
risk stori term guidanc go forward believ stock continu lift
manag execut better expect margin improv
revenu headwind may subsid potenti near term could substanti catalyst
share reiter overweight rate find solid entri point
lower price trim price target base
ebitda assum net debt s/o due
rerat stock lower outlook busi
page
sourc compani report piper jaffray co estim
page
market incom expens net incom tax net analysi gross gener oper inc
million
sale
market administr
revenu report
percent sale
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
